SCA
Stuart Chaussee & Associates’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5K | Hold |
165
| – | – | ﹤0.01% | 144 |
|
|
2025
Q1 | $12.1K | Hold |
165
| – | – | ﹤0.01% | 143 |
|
|
2024
Q4 | $10.8K | Hold |
165
| – | – | ﹤0.01% | 143 |
|
|
2024
Q3 | $12.9K | Hold |
165
| – | – | ﹤0.01% | 124 |
|
|
2024
Q2 | $12.9K | Hold |
165
| – | – | ﹤0.01% | 119 |
|
|
2024
Q1 | $11.2K | Hold |
165
| – | – | ﹤0.01% | 123 |
|
|
2023
Q4 | $11.1K | Hold |
165
| – | – | ﹤0.01% | 113 |
|
|
2023
Q3 | $11.2K | Hold |
165
| – | – | ﹤0.01% | 88 |
|
|
2023
Q2 | $11.8K | Hold |
165
| – | – | ﹤0.01% | 85 |
|
|
2023
Q1 | $11.5K | Hold |
165
| – | – | ﹤0.01% | 81 |
|
|
2022
Q4 | $11.2K | Hold |
165
| – | – | ﹤0.01% | 94 |
|
|
2022
Q3 | $9K | Hold |
165
| – | – | 0.02% | 93 |
|
|
2022
Q2 | $11K | Hold |
165
| – | – | 0.02% | 93 |
|
|
2022
Q1 | $11K | Hold |
165
| – | – | 0.01% | 108 |
|
|
2021
Q4 | $10K | Hold |
165
| – | – | ﹤0.01% | 119 |
|
|
2021
Q3 | $10K | Hold |
165
| – | – | 0.02% | 97 |
|
|
2021
Q2 | $10K | Hold |
165
| – | – | ﹤0.01% | 104 |
|
|
2021
Q1 | $8K | Buy |
+165
| New | +$8K | ﹤0.01% | 134 |
|